00867.HK
China Medical System Holdings Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 11.04
−0.36%Year over year
Reported trailing growth
- Revenue
- +1.1%
- EBITDA
- -24.6%
- EBIT
- -34.3%
- EPS
- -33.3%
- Free cash flow
- -95.5%
- Operating cash flow
- -86.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -3.5%
- EBITDA
- -21.4%
- EBIT
- -23.7%
- Net income
- -23.0%
- EPS
- -22.5%
- Free cash flow
- -56.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026